Search

Your search keyword '"Wauters, Els"' showing total 292 results

Search Constraints

Start Over You searched for: Author "Wauters, Els" Remove constraint Author: "Wauters, Els"
292 results on '"Wauters, Els"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Acute kidney injury in patients treated with immune checkpoint inhibitors

3. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study

8. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19

10. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps

12. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort

13. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

14. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

15. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

16. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk.

17. Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

18. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

20. Trial watch: chemotherapy-induced immunogenic cell death in oncology

21. Phenotype molding of stromal cells in the lung tumor microenvironment

22. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients

23. Trial watch:chemotherapy-induced immunogenic cell death in oncology

25. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

26. Radiologic and Histologic Correlates of Early Interstitial Lung Changes in Explanted Lungs

28. Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma

30. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates

31. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

32. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project

35. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis

36. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution

37. Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology

38. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

40. Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma.

41. Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma

42. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts

43. Impact of Selection Bias on Estimation of Subsequent Event Risk

44. Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

45. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets

47. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

48. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza

49. The Belgian Multidisciplinary Immunotoxicity Board (BITOX): A nationwide initiative of the Belgian Society of Medical Oncology (BSMO)

50. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Catalog

Books, media, physical & digital resources